Archives: Speakers

DJ Singh is Vice President Of Sales at Canary Technologies and has led the global sales team for the past 5 years. DJ has partnered with leading hotel brands, including Four Seasons, Rosewood, Wyndham, Club Quarters, Millennium, and many more.

Rob is the Regional Director, sub-Saharan Africa for the OXIMIO Group, a global End-to-end logistics provider for the Clinical Supply Chain. Oximio provide GDP storage and distribution, procurement, and comparator sourcing as well as reverse logistics for Biospecimens throughout EU, Europe, CIS and MENA regions, as well as sub-Saharan Africa.

​OXIMIO Kenya provides a Gateway IN2Africa as a Customs Bonded Depot, for faster turnaround time, reduced costs and substantially improved access to medicine, to the difficult to reach areas and the marginalised throughout all regions.

​Rob’s 22years experience in Clinical Supply Chain, has fostered successful, long-term relationships with local and international Pharma. His insatiable appetite as a Solution Provider for business growth, prompted him to travel abroad, resulting in attracting multiple distribution contracts for Clinical Trial Projects throughout sub-Saharan Africa.

Business innovator bringing ‘first mover’ tech-driven solutions for leading travel companies since 1997, including a European first B2B e-commerce solution.
Bojan is co-founder at Epteca, an emerging technology company bringing unique ‘smart selling and personalization’ capabilities to airlines, hotels, and premium brands worldwide, resulting in new revenue streams and enhanced guest experience.

Andrea earned her B.S. in Biotechnology and M.S. in Biology and then began her career in the lab working on process development and validation before transitioning to a quality role.  Andrea has spent time in Quality Systems, Compliance, and Operations positions but now specializes in leading a QA Operations team supporting the CMC functions of early phase clinical programs through commercialization.

As Manager of Product development Services at Sharp, Vinay is responsible for supporting R&D formulations by leading a team of scientists and product development leading to CTM manufacturing of products for clinical studies and subsequent regulatory filings. Vinay has over 7 years of R&D experience and clinical trials. He has started his career as Formulation Scientists and worked over more than 50 projects which includes NDAs and ANDAs throughout his career journey over the course of his career and has expertise in oral solid dosage form.

Vinay holds master’s degree in industrial pharmacy from University of Long Island, NY and a bachelor’s degree in Pharmaceutics from Pune University, India.

As the Director of Analytical and Formulation Services, Robert is responsible for leadership of product development, GMP manufacturing, and analytical laboratory personnel. Robert has over 18 years of QC and R&D experience in the pharmaceutical industry as a subject matter expert in CMC sections of regulatory submissions. He also serves as a primary scientific reviewer on third-party research and development projects and provides expert guidance on identifying chemical degradation pathways, impurity purification, and qualification.

Chris Casazza is an executive team leader with over two decades of experience driving commercial success and R&D excellence in the Pharma and Biotech sectors.  Chris has held pivotal leadership roles at Kantar Health (now part of Oracle Life Sciences), YourEncore, and Advarra.  In his current role as Chief Commercial Officer at Diligent Pharma, Chris manages all commercial aspects of the company’s operations and is deeply involved in growing the vision and culture of the company.